Dice CEO: Energy, T...
Health Care: Drugs
Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)
$87.60 -2.97 | -3.28%
06/01/12 - 04:00 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 175.32M | 97.03M | 295.17M | 33.15M |
| Operating Gains/Losses | 615.00K | 76.00K | 271.00K | 44.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -78.78M | -59.24M | -36.44M | -31.26M |
| (Increase) Decrease in Inventories | -12.18M | -14.12M | 14.60M | -15.70M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 79.78M | 47.46M | 14.13M | 32.91M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 15.03M | 1.32M | 400.00K | 1.34M |
| Other Non-Cash Items | 51.68M | 38.02M | 28.90M | 24.16M |
| Net Cash From Continuing Operations | 270.08M | 160.91M | 113.84M | 53.20M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 270.08M | 160.91M | 113.84M | 53.20M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 94.46M | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -21.98M | -12.84M | -63.02M | -48.36M |
| Acquisitions | -105.89M | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | -129.86M | -19.03M | -206.78M |
| Other Cash from Investing Activities | -307.00K | -2.00K | 618.00K | 339.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -33.72M | -89.32M | -81.42M | -38.65M |
| Issuance of Debt | 60.00M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 35.76M | 37.55M | 30.73M | 28.89M |
| Repayment of Long-Term Debt | -60.73M | -649.00K | -44.35M | -585.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 4.02M | 1.97M | -652.00K | 0.00 |
| Net Cash From Financing Activities | 39.05M | 38.87M | -14.27M | 28.31M |
| Effect of Exchange Rate Changes | -1.70M | -482.00K | 1.01M | -166.00K |
| Net Change in Cash & Cash Equivalents | 273.72M | 109.97M | 19.16M | 42.69M |
Portfolios with ALXN
- Portfolio NameUser Type
- UserLong Term Stock Picks by Co...
- UserGFNN Stockdiagnostics 17
- ContributorBreakout Stocks Of The Week...
- UserWatchlist-CTS
- UserFreewilly's Stockpicker Blo...
- UserFinancial Machine.
- UserHealth
- UserGFNN Stockdiagnostics 11
- UserRookie
- UserGFNN Stockdiagnostics 4
Latest ALXN Headlines from TheStreet
- 5 Stocks Poised for Breakouts 05.25.12 | 11:05 am
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner 05.22.12 | 05:05 pm
- 3 Stocks I Saw on TV, May 17
05.17.12 | 07:05 am - Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Drugs Winner 05.15.12 | 05:05 pm
- Alexion Pharmaceuticals Management Presents At Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript) 05.11.12 | 06:05 pm
- Vertex Is the Next Gilead Sciences or Alexion 05.07.12 | 11:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- Alexion Pharmaceuticals Inc. (ALXN): Today's Featured Health Care Winner 05.01.12 | 05:05 pm
- Alexion's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.24.12 | 04:04 pm
- The Week Ahead: Housing Data, GDP and Earnings 04.22.12 | 06:04 pm
Press Releases for ALXN
- Alexion To Present At Investor Conferences - Business Wire 05.29.12 | 10:05 am
- Alexion To Present At Deutsche Bank Securities 37th Annual Health Care Conference - Business Wire 04.30.12 | 10:04 am
- Alexion Reports First Quarter 2012 Results - Business Wire 04.24.12 | 06:04 am
- Alexion Pharmaceuticals To Report First Quarter 2012 Results On Tuesday, April 24, 2012 - Business Wire 04.10.12 | 10:04 am
- Asfotase Alfa Significantly Decreased TNSALP Substrates And Improved 6-Minute Walk Test Results In Adolescents And Adults With Hypophosphatasia (HPP) - Business Wire 03.29.12 | 11:03 am
- New England Journal Of Medicine Publishes Data From Phase 2 Study Of Asfotase Alfa In Life-Threatening Hypophosphatasia - Business Wire 03.07.12 | 05:03 pm
- Alexion To Present At Barclays Capital Global Healthcare Conference - Business Wire 03.06.12 | 10:03 am
- Alexion Joins EURORDIS, NORD And Patient Organizations Worldwide In Celebrating Rare Disease Day 2012 - Business Wire 02.29.12 | 06:02 am
- Alexion To Present At The Cowen And Company 32nd Annual Health Care Conference - Business Wire 02.27.12 | 10:02 am
- Alexion To Present At The Leerink Swann 2012 Global Healthcare Conference - Business Wire 02.10.12 | 10:02 am
Partner Headlines for ALXN
- Some Leaders Building Bases As Market Corrects - Investor's Business Daily 05.31.12 | 06:05 pm
- Leaders Stage Comeback; Some Form Bases - Investor's Business Daily 05.25.12 | 06:05 pm
- After Hours Most Active for May 24, 2012 : EP, KMI, ALXN, S, XRX, GLW, WMB, QQQ, ORCL, FB, TEVA, TIBX - NASDAQ 05.24.12 | 08:05 pm
- Stock Market Gains Fade After Higher Open - Investor's Business Daily 05.24.12 | 10:05 am
- Some Quality Stocks Are Working On Potential Bases - Investor's Business Daily 05.23.12 | 02:05 pm
- Stocks Gain, But Facebook Does Another Face Plant - Investor's Business Daily 05.22.12 | 03:05 pm
- Stocks Advance In Mixed Volume; Retailer DSW Hits New High - Investor's Business Daily 05.22.12 | 01:05 pm
- Stocks Gain In Mixed Turnover; Mellanox Breaks Out - Investor's Business Daily 05.22.12 | 12:05 pm
- Stock Futures Narrowly Higher; Best Buy Surges - Investor's Business Daily 05.22.12 | 09:05 am
- Stocks Surge As China Vows Growth Push - Investor's Business Daily 05.21.12 | 04:05 pm
